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Abstract More than three decades ago, basement mem-
branes (BMs) were described as membrane-like structures
capable of isolating a cell from and connecting a cell to its
environment. Since this time, it has been revealed that BMs
are specialized extracellular matrices (sECMs) with unique
components that support important functions including
differentiation, proliferation, migration, and chemotaxis of
cells during development. The composition of these sECM
is as unique as the tissues to which they are localized,
opening the possibility that such matrices can fulﬁll distinct
functions. Changes in BM composition play signiﬁcant
roles in facilitating the development of various diseases.
Furthermore, tissues have to provide sECM for their stem
cells during development and for their adult life. Here, we
brieﬂy review the latest research on these unique sECM
and their components with a special emphasis on embry-
onic and adult stem cells and their niches.
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Introduction
The extracellular matrix (ECM) provides a chemical and
mechanical structure, which is essential for development
and for responses to (patho)-physiological signals [1].
Differentiation and cell fate decisions are controlled by
their surrounding microenvironment of which the ECM is
one of the main constituents [2]. The diverse characteristics
of the ECM, such as stiffness and composition, have been
recognized as being responsible for the variation of cellular
behavior involving an individual’s health [3, 4].
Basement membranes (BMs) are highly specialized
extracellularmatrices(sECMs)formingthinacellularlayers
that underlie cells and separate the cells from and connect
them to their interstitial matrix [5]. The formation of BMs is
aprerequisitefornormaltissuedevelopmentandfunction[6,
7]. In addition, individual components of BMs regulate
different biological activities, such as the development,
proliferation, differentiation, growth, and migration of cells,
via cell surface receptors (mostly integrins) and non-inte-
grin-receptors [8]. Furthermore, BMs control cellular
functions by binding and modulating the local concentra-
tions of growth factors and cytokines [4, 9]. BMs are able to
regulate cell polarity [10, 11], cell adhesion, spreading, and
migration via their effects on the cytoskeleton [12–14].
Adult tissues need ahighly selective sECM to maintaintheir
stem cell properties particularly in stem cells during devel-
opment [15, 16] and it has been shown that BMs have been
implicated in niche function [17].
BMs are made of diverse extracellular matrix mole-
cules depending on the tissue in which they are localized.
Due to the discovery of new components and isoforms,
the complexity of BM composition has been considerably
increased, providing an impressive number of tissue- and
site-speciﬁc BMs [18]. The ability of BMs to adapt to
changing cell biological requirements is dependent on
how the components are deposited and arranged inside the
matrix (for review, see [14, 19]). The deposition of BM
components is also dependent on aging, as has been
demonstrated using mouse retina and cartilage tissue [20,
21]. BM components can also be localized in the ECM,
independent of the typical membrane-like structures seen
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BM components are found in the pericellular matrix of
human and murine cartilage and osteoarthritis disease
[21–23]. In the lymph nodes, BM components are
deposited outside a BM structure [5]. Changes in the
qualitative or quantitative composition, localization, or
structure of BM proteins have been shown to be involved
in the development of different disease states as discussed
in detail below.
Herein, we want to brieﬂy introduce the ubiquitous
components of the BM including laminins, perlecan, col-
lagen IV, nidogen-1, and nidogen-2 [5], with emphasis
placed on their variable tissue distributions. We will further
discuss the role of BM components and their uniqueness in
different stem cell niches.
Ubiquitous BM components at a glance
Excellent detailed reviews regarding these unique matrix
proteins and receptors, such as integrins, have just recently
been published and the reader is directed to these reviews
for comprehensive information [4, 14, 24–33]. An over-
view can be found in Table 1.
Laminins
Laminins are heterotrimeric glycoproteins, which are
composed of three chains including one a, one b, and one c
chain. Five alpha, four b, and three c chains exist, and in
vertebrates, these chains can assemble into at least 16 [25]
different isoforms [14, 34]. These isoforms are differen-
tially distributed during development and in adult tissues,
thereby fulﬁlling speciﬁc functions as key regulators of
tissue structure and cell behavior [35]. In general, laminin-
111 and laminin-511 are the main laminins required during
embryonic development (Fig. 1a, b), whereas other lami-
nins have been identiﬁed as being important for organ
maturation and speciﬁc tissue functions [26]. For instance,
laminin-211 and laminin-221 are mainly found in skeletal
muscle [36, 37]. Laminin-221, -421 and -521 are localized
to the neuromuscular junction and coordinate postsynaptic
with presynaptic maturation [38]. Laminin-511 is the major
laminin in ectodermal BM and in most epithelium
including the skin, kidney, and lung to name a few. Lam-
inin-332 plays a major role in skin function [39].
Furthermore, laminin-332 has been previously shown to be
transiently expressed in embryonic cartilage [40]. Laminin-
111 has been observed in the chondrocytes of healthy
human cartilage especially that which is localized to the
superﬁcial layer [41] where the mesenchymal progenitor
cells are localized [42, 43]. In the vasculature, laminin-411,
-421, -511 and -521 can be found. Although this laminin
deposition appears to be signiﬁcantly varied, the tissue
distribution of laminins is mainly dependent on the
expression of its alpha subunits, though the mechanisms
are not yet fully understood [25]. However, it is well
known that alpha subunits and their speciﬁc interaction
with integrins or non-integrin receptors are essential for the
self-assembly and polymerization of laminin networks.
This network assembling is a prerequisite for basement
membrane formation [25, 26]. To name just a few laminin-
receptor speciﬁcities, a-dystroglycan presumably binds
laminin a1 and a2 chains, whereas the Lutheran blood
group glycoprotein binds only laminin a5 chains. Integrins
such as a3b1, a6b1 and a6b4 can regulate the deposition of
laminin-332 in keratinocytes [14] and interact with laminin
a5 chains [26]. Further integrin receptors for laminins are
known as the a1b1, a2b2, a7b1 (via laminin a2), a9b1, and
avb3 (via laminin a4) receptors, as well as the non-integrin
receptor syndecans [25].
It has been demonstrated by immunogold electronmi-
croscopy that laminin-111 is oriented differently inside the
BM of the same tissue, for tissues such as the proximal and
distal tubule (Fig. 1c, d) of the murine kidney [44]. Fur-
thermore, laminin-211 and -221 that are located in
Schwann cells are deposited in mesh-like structures for
organizing the receptors and cytoskeletal elements [45],
whereas a ﬁbrillar network, for example, of laminin-311 in
the lung seems ideal for the transmission of mechanosig-
nals such as stretch [46]. The pattern and stabilization of
laminins is further inﬂuenced by other BM components,
such as nidogens or perlecan [14]. Moreover, the deposi-
tion pattern of laminin-332 has been shown to vary for non-
migratory and migratory keratinocytes in vitro. While non-
motile cells revealed a rosette-like pattern of laminin-332
in their matrix, motile cells assembled trails for migration
[13]. Under physiological or pathological conditions (e.g.,
metastasis), fragments of laminins not able to polymerize
into networks are deposited into the ECM, thereby stimu-
lating cell migration as shown for laminin-332 [47–49].
According to the functions of laminins in BMs, it should
be mentioned that the ability of laminin subunits to accu-
mulate into heterotrimers and further assemble networks is
absolutely required for the initial BM assembly [26]. In
Drosophila, it has been shown that the complete absence of
laminin leads to the complete absence of BMs resulting in a
disorganized ECM and an abnormal accumulation of major
BM components. Organ and tissue development is subse-
quently prevented in the gut, muscle and nervous system
[50]. The important functions of laminin isoforms in tissues
can further be demonstrated by analysis of knockout mice
or of various mutations in mice, which also resemble
human diseases. Most laminin subunit knockouts are lethal,
such as laminin c1[ 7], due to the lack of BM formation
[25]. If the mice survive, they develop severe diseases,
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BM isoform Interactive
receptors/ligands
Site of expression Phenotypes of
deﬁcient mice
Involvement in
human diseases
Laminin-111 Lam a1: a-
dystroglycan
Development,
ubiquitously in
BMs, adult
articular cartilage
Lam c1: lethal
Laminin-211 Lam a2: a7b1, a-
dystroglycan
Skeletal muscle,
schwann cells,
eye (limbal
compartment)
Lam a2: congenital muscular
dystrophy
Congenital muscular
dystrophy
Laminin-221 Skeletal muscle,
schwann cells,
neuromuscular
junction
Lam b2: defective, disorganized
neuromuscular junctions
Pierson syndrome
Laminin-332 Lam a3: a3b1,
a6b1, a6b4
Skin, embryonic
cartilage
Severe skin blistering disease Epidermolysis
bullosa
Fragments: cancer/
metastasis
Laminin-411 Lam a4: avb3 Vasculature Lam a4: hemorrhaging,
cardiomyopathy
Inﬂammation
Lam a4 increased in
cancer/metastasis
Laminin-421 Vasculature,
neuromuscular
junction
Laminin-511 Lam a5:
Lutheran
Bloodgroup
glycoprotein,
B-CAM, a3b1,
a6b1, a6,b4
Development,
vasculature,
epithelium
Lam a5: impaired hair follicle,
teeth growth and development,
defective glomerulogenesis
Lam a5 decreased in
cancer/metastasis
Perlecan Interaction with
and support of
diverse growth
factors
Ubiquitously in
BMs, articular
cartilage, growth
plate
SJS: chondrodysplasia, myotonia,
short stature
DDSH: lethal, chondrodysplasia,
exencephaly, abnormal heart
development, absence of
acetylcholinesterase at
neuromuscular junction
SJS, DDSH (lethal)
Osteoarthritis,
cancer/metastasis
Collagen IV-(112) a1b1, a2b1 Development,
ubiquitously in
BMs
Lethal Collagen IV a1:
HANAC
syndrome,
encephaloclastic
porencephaly,
recurrent
hemorrhagic
stroke
Collagen IV-(345) a3b1, a6b1,
a10b1, a11b1,
avb3, CD44,
DDR-1
Kidney, inner ear
(cochlea), eye,
testis, lung
Collagen IV a3, a4o ra5 ? Alport
syndrome: progressive renal
failure/ﬁbrosis, disrupted
glomerular BM, deafness and
retinopathy, lethal
Alport syndrome
Goodpasture
syndrome
Collagen IV-(556) Bowman0s capsule
(kidney), skin,
esophagus,
smooth muscle
cells, synovia
(knee)
Every collagen IV
isoforms as
fragments:
metastasis (?)
Basement membrane components 2881according to the subunits and their tissue distributions.
Laminin a2 deﬁciency, known to affect humans, causes
congenital muscular dystrophy [51], while laminin b2
deﬁciency, known in humans as Pierson syndrome, results
in disorganized and defective neuromuscular junctions [52,
53]. Laminin a5 deﬁciency causes impaired hair follicle,
teeth growth and development issues [54] as well as
defective glomerulogenesis [55]. Laminin-332 mutations
are related to epidermolysis bullosa, a severe skin blistering
disease [56, 57], while laminin a4 mutations cause hem-
orrhaging and cardiomyopathy [58]. Furthermore, laminins
are known to be involved in cancer development and
metastasis [48]. Additionally, laminins have been shown to
play a role in the growth and/or differentiation of embry-
onic and adult stem/progenitor cells, which will be
discussed in detail below.
Table 1 continued
BM isoform Interactive
receptors/ligands
Site of expression Phenotypes of
deﬁcient mice
Involvement in
human diseases
Nidogen-1 avb3, a3b1,
Laminin c1,
collagen IV,
perlecan,
ﬁbronectin,
collagen I,
collagen II
Ubiquitously in
BMs, limb
development, rib
anlagen, adult
articular cartilage
Single: neurological defects,
epilepsy, structural alterations in
brain capillaries and lens
capsule, impaired wound
healing
Osteoarthritis,
metastasis (?)
Nidogen-2 Laminin,
collagen IV,
perlecan,
ﬁbronectin,
collagen I,
collagen II
Like nidogen-1, but
more restricted in
muscle,
neuromuscular
junction and
cartilage
Single: no phenotype
Both nidogens: lethal, syndactyly,
lung and heart abnormalities,
microhemorrhaging of skin
Osteoarthritis
Ovarian cancer
(biomarker?)
Lam Laminin, SJS Schwartz-Jampel-syndrome, DDSH dyssegmental chondrodysplasia of the Silverman-Handmaker-Type, HANAC hereditary
angiopathy with nephropathy, aneurysm and muscle cramps
Fig. 1 Laminin-111 is found in
the very early mouse embryo,
here shown at day 6, even
before a proper BM has
assembled (a) and in BM
remnants of migrating
mesodermal cells (b) at day 7.
M Mesodermal cell, N nucleus,
S mesodermal space, EC
ectodermal cell. (Taken from
[200], with permission from the
publisher). In adult murine
kidney, the tail (formerly the E8
domain) of laminin-111 is
orientated towards the lamina
ﬁbroreticularis in the basement
membrane of the proximal
tubule (c), while the molecule is
randomly distributed in the
distal tubule (d). C Cell, BM
basement membrane. (Taken
from [44], with permission from
the publisher)
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Perlecan is a proteoglycan composed of ﬁve domains, and
like laminins, has the ability to self-assemble into oligo-
mers [59]. Structurally, perlecan exhibits potential sites for
glycosaminoglycan-(GAG)-chains proximal to its protein
core like heparan sulfate (HS) and chondroitin sulfate (CS).
Both the protein core and the GAG-chains are able to
interact with diverse ECM molecules including all the main
BM components, growth factors and receptors [28, 29],
thereby initiating and controlling the migration, prolifera-
tion and differentiation of different cells by mediating cell
signaling events. As typical for proteoglycans, perlecan
mediates these functions by mainly controlling growth
factor signaling and activation of ﬁbroblast growth factors
(FGFs), bone morphogenic proteins (BMPs), platelet-
derived growth factor (PDGF), vascular endothelial growth
factors (VEGFs), transforming growth factors (TGFbs),
epithelial growth factor (EGF), hepatocyte growth factor
(HGF), and insulin-like growth factor (IGF) [28, 59–62].
Perlecan is important in the developmental processes
[63] that occur during angiogenesis [64], anti-angiogenesis
[65], cardiovascular development [66], neurogenesis [67],
and chondrogenesis [68]. Although there is only one perl-
ecan, tissue-dependent structural differences have been
reported [28, 68]. The GAG-chains can vary between dif-
ferent tissues enabling perlecan to fulﬁll tissue-speciﬁc
functions, such as signiﬁcant amounts of HS-chains that are
important for endothelial cells and angiogenesis [28].
However, in articular cartilage, particularly high amounts
of CS-chains are found. The GAGs of perlecan play crucial
roles in the differentiation potential of cells [69]. Interest-
ingly, these cartilage-speciﬁc perlecan CS-chains are also
able to inﬂuence ECM by stimulating collagen ﬁbril for-
mation [70]. Furthermore, a fragment of perlecan,
endorepellin (domain V of perlecan), has anti-angiogenic
functions due to integrin a2b1 and is thought to be a
potentially useful tool in future cancer therapy [71].
Mutations, resulting in reduced perlecan, resembles
Schwartz-Jampel syndrome (SJS) in humans [72, 73].
Patients develop skeletal chondrodysplasia and myotonia
and are characterized by short stature. Moreover, a total
knockout of perlecan in humans and mice results in
dyssegmental chondrodysplasia of the Silverman-Hand-
maker type (DDSH) and early lethality due to respiratory
distress [74]. A severe chondrodysplasia, ex- or microen-
cephaly, abnormalities in heart development and the
absence of acetylcholinesterase at the neuromuscular
junction have been observed [72, 74]. ECM and BM dis-
ruption appear to be major factors for these ﬁndings, as
cartilage ECM and BM integrity has been found to be
mainly interrupted in the cartilage, heart and brain tissue
[67, 75]. Furthermore, perlecan has been shown to increase
in osteoarthritic cartilage (Fig. 2), possibly due to regen-
eration efforts [23].
Collagen IV
Collagen IV is made up of 6 different alpha chains that can
assemble into 3 different heterotrimers, a1a1a2(IV),
a3a4a5(IV), or a5a5a6(IV) [27, 76]. These combined
networks show a tissue-speciﬁc distribution (Fig. 3) and
thereby deﬁne BM structure and function [77]. During
development, collagen, which is an a1a1a2(IV) network, is
ubiquitously distributed in BMs. During the maturation
process, this network gets partially replaced, for example,
by collagen a3a4a5(IV) in the glomeruli of the kidney, in
the cochlea, eyes, testis and lung, and by collagen
a5a5a6(IV) in the bowman0s capsule of the kidney, the
skin, esophagus and smooth muscle cells [78] as well as in
the human synovial lining of the knee joint [79].
The mechanical stability, as opposed to the assembly of
BMs, is largely dependent on its collagen IV scaffold [77,
80]. Many different cells have been shown to bind to col-
lagen IV including platelets, hepatocytes, keratinocytes,
and endothelial, mesangial, and pancreatic cells, as well as
diverse tumor cells [27]. These interactions are mediated
by integrins and non-integrin receptors, which show a
collagen IV chain-speciﬁc binding [27]. Integrins such as
a1b1, a2b1, a3b1, a6b1, a10b1, a11b1, avb3, and avb5
have been described [27], while non-integrin receptors
such as CD44 [27] and discoidin domain receptor-1 (DDR-
1) have been reported [81]. DDR-1-collagen IV interac-
tions have been demonstrated to be important for the
structural integrity and ﬁltration function of the BMs in the
kidney [82].
Fig. 2 Perlecan is found in the
pericellular matrix next to a
healthy chondrocyte (a) and
increased amounts next to an
elongated chondrocyte (b) from
osteoarthritic tissue. (Taken
from [23], with permission from
the publisher)
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or denaturation of collagen IV results in novel binding sites
[83] that could further effect and alter integrin speciﬁcity
and the biological functions of collagen IV [27]. This
proteolytic cleavage, for example, was shown to support
angiogenesis [84]. Furthermore, a proteolytic fragment of
a3(IV), namely tumstatin, has anti-angiogenic activity and
is discussed as a potential candidate for cancer therapy
[85].
Notably, the a1(IV) and a2(IV) mutations are typically
embryonic lethals [77]. However, in humans, mutations in
the a1(IV) may not be lethal and can exhibit a phenotypic
heterogeneity. A cerebrovascular disease, known as HA-
NAC syndrome (hereditary angiopathy with nephropathy,
aneurysm and muscle cramps), has been described [86].
Furthermore, neurological diseases such as encephalo-
clastic porencephaly or vascular diseases such as recurrent
hemorrhagic stroke are associated with mutations in col-
lagen a1(IV) [86]. Autoantibodies against the a3(IV) chain
leads to Goodpasture syndrome, a rapidly progressive
glomerulonephritis associated with lung hemorrhage [87].
In addition, a3(IV), a4(IV) or a5(IV) mutations cause Al-
port syndrome, which leads to renal failure, deafness and
retinopathy in patients [27, 88, 89]. Stem cell therapies that
could beneﬁt Alport syndrome have just recently been
described [90].
Nidogens
Nidogen-1/entactin-1 [91] and nidogen-2/entactin-2 [92]
are BM glycoproteins. Structurally, they appear highly
similar. Both nidogens consist of three globular domains
that are separated by a link-like and a rod-like region
[92, 93]. In addition, both are known to act with a wide
range of BM proteins [30, 91, 92]. Nidogens are mainly
expressed by mesenchymal cells and are deposited into the
epithelial and endothelial BMs during development [94]. In
skin tissue, ﬁbroblasts have been described to be the source
of nidogens [92, 95]. Nidogen-1 and nidogen-2 have been
observed in the mesenchyme of different murine tissues
during limb development [96] and have been shown to
exist in the rib anlagen [97]. Furthermore, both nidogens
have been described in murine and human adult articular
cartilage [21, 22].
Due to their similar structure and afﬁnity to comparable
ECM proteins, nidogens are thought to have similar func-
tions such that they are capable of compensating for each
other [97]. Indeed, in nidogen-1 or nidogen-2 knockout
mice, BM formation is not interrupted [98]. Furthermore, a
compensatory process has been shown for nidogen-2 in
nidogen-1 knockout mice (Fig. 4), especially in muscle and
heart tissue [99]. Nidogen double-knockouts are smaller
than their wild-type littermates [100], exhibit syndactyly,
and some of these animals have more severe defects of the
skeleton, such as hypoplasia [101]. A double knockout
leads to perinatal death as a consequence of lung and heart
anomalies and BM defects [100, 102]. Also, the capillary
BMs were disrupted with an almost complete loss of
laminin-411 and reduction of collagen IV and perlecan,
thereby causing microhemorrhages of the skin. However,
some BMs still develop without abnormalities, such as the
dermal–epidermal junction [103].
Nidogens are able to interact with different receptors
and nidogen-2 has an even more restricted tissue distribu-
tion (e.g., in muscle tissue) at the neuromuscular junction
[104, 105] or in cartilage tissue (Fig. 5)[ 22]. While nido-
gen-1 integrins such as avb3 and a3b1 have been described
[106, 107], interactions with these integrins could not be
observed for nidogen-2 [22, 92]. Nidogen-1 knockout mice
developed neurological defects, showed altered anionic
charges in the glomerular BM, were observed to have
structural alterations in the BMs of brain capillaries and the
lens capsule and were characterized with impaired wound
healing [108–111]. These ﬁnding indicate diverse functions
of nidogens.
Due to their strong afﬁnity to laminin and collagen IV,
nidogens are considered to be link-proteins in some BMs
[30]. In particular, the laminin c1-nidogen-1 complex has
been shown to be important during organ development [94,
112, 113]. Nidogens are highly sensitive to proteolytic
cleavage; however, laminin c1-binding can decrease this
strong susceptibility to proteolysis as shown for nidogen-1
[113]. Moreover, the same protective effect has been
reciprocally demonstrated [94], therefore the removal of
nidogens might initialize BM disintegration. Furthermore,
while they could be ideally suited for maintenance, they
Fig. 3 The interconnected networks of laminin-111 (large gold
particles) and collagen IV (small gold particles) is here shown in a
basement membrane of the kidney. The inset shows a higher
magniﬁcation. BM Basement membrane. (Taken from [201], with
permission from the publisher)
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and might be early targets in tissue destruction pathways,
such as metastasis [31]. Just recently, nidogen-2 has been
observed to be strongly upregulated in the serum of
patients with ovarian carcinoma and has been proposed as
an additional cancer biomarker [114].
A stem cell’s niche is its specialized ECM
Stem cells are important during development, regeneration
and cancer development [115]. Embryonic stem cells
(ESCs) are undifferentiated cells with the ability to develop
into different tissues, whereas adult stem cells are thought
to reside in speciﬁc tissues, with the possibility to regen-
erate the tissue if needed. Stem cells are embedded in a
highly tissue-speciﬁc environment, which consists of an
ECM with additional surrounding cells, such as organ-
speciﬁc mesenchymal cells [15]. A stem cell niche is
deﬁned as a microenvironment that regulates the mainte-
nance, self-renewal, activation, proliferation and long-term
regenerative capacity of stem cells via external signals. The
niche is, therefore, a key prerequisite for proper stem cell
function and fate determination [15, 116, 117]. A single
sECM, along with integrins, growth factors and diverse
proteases are interconnected in complex pathways in stem
cell niches. Stem cell niches are thought to be anatomically
localized in protected sites of tissues [118]. Deﬁning the
composition of stem cell niches would help to understand
the regulation of stem cells and to exploit their therapeutic
potential [9]. Furthermore, knowledge about niches in
different organs can help to elucidate the emergence of
Fig. 4 More nidogen-2 is found in the BM of skeletal muscle in
nidogen-1 knockout mice compared to control mice (a), sparse
labeling of muscle BM of a control mouse (b), and a higher amount
seen in a nidogen-1 knockout mouse (c). (Taken from [99], with
permission from the publisher)
Fig. 5 Nidogen-2 (b) exhibits a more restricted tissue distribution in
human articular cartilage than nidogen-1 (a). (Taken from [22], with
permission from the publisher)
Basement membrane components 2885diseases including diabetes, neurodegenerative diseases,
cancer development and metastasis [60].
BMs are capable of governing cell fate by inducing
signaling cascades, as well as stabilizing cellular struc-
tures. Thus, its components could potentially be used in
stem cell and gene therapy approaches [119]. Over the
last few years, there has been signiﬁcant progress made
in characterizing different stem cell compartments, such
as the hematopoietic, epidermal, intestinal or neural stem
cell niches [120–122]. Most niches contain a BM, to
which stem cells attach [17]. The BMs are believed to
have important functions for the structural integrity of
stem cells [123]. They are also important for facilitating
the polarization of cells, which is a prerequisite for
proper symmetric and asymmetric cell division [61, 118,
124]. It has been suggested that, in contact with a BM,
cells maintain their stemness, whereas cells that have
detached from the BM undergo terminal differentiation
[9].
Embryonic stem cells and their BM components
Human embryonic stem cells (hESCs) are seen by some as
a potential source for therapeutic approaches, due to their
indeﬁnite proliferation in culture and ability to differentiate
into various cell types [125]. Embryonic stem cells are
colony-forming adherent and undifferentiated cells. Their
adhesion mechanisms are important for their survival and
differentiation and are thought to include a special ECM.
Recently, it has been found that laminin-511 and nidogen-1
are expressed by human embryonic stem cells [126]. In
addition, Lutheran-glycoprotein and its truncated form,
basal cell adhesion molecule (B-CAM), which is a laminin-
511-receptor, has been reported. Furthermore, adhesion of
hESCs was driven by a3b1 via laminin-511. Moreover,
hESCs have been found to be positive for laminin-111
[127]. In vitro, single ESCs were able to reassemble into
embryoid bodies with the aid of a laminin–nidogen–com-
plex via a6b1 integrin, subsequently differentiating into
endodermal, ectodermal and mesodermal derivates, as well
as hematoendothelial progenitors [126]. Mimicking stem
cell niches as a ﬁbrous scaffold with a BM texture has been
shown to increase the expansion of hematopoietic and
ESCs [128]. Proper BM formation seems to be involved in
the maintenance of the differentiation status of BM-cou-
pled cells such as in the myotome or the central nervous
system [129, 130]. During development, BMs seem to have
an inhibitory effect on the progression of cell differentia-
tion [131]. Notably, other reports have found that hESCs
retained their undifferentiated state if cultured on Matri-
gel
 (includes mainly laminin-111), whereas hESCs
underwent differentiation on substrates like ﬁbronectin
[132, 133].
BMs are important contributors during epithelial-
mesenchymal-transition (EMT)
During development, undifferentiated cells in contact with
BMs become polarized and as a consequence form the
ectoderm [131]. Furthermore, using ESC-derived embryoid
bodies (EBs), evidence demonstrates that unpolarized cells
that fail to contact the BM undergo apoptosis, which leads
to cavitations that create the proamniotic cavity [131, 134,
135].
Gastrulation, which leads to the formation of the
mesoderm and endoderm, involves an event known as the
epithelial-mesenchymal-transition (EMT). During this
process, cells of the primitive ectoderm become activated
by exogenous stimuli, followed by a loss of contact with
the neighboring cells and the underlying BM that promotes
the migration of cells into the space between the ectoderm
and the extraembryonic endoderm [131]. Fujiwara et al.
[131] proposed that the BM not only promotes the epi-
thelialization of primitive ectoderm cells [135] but also
promotes mesodermal differentiation by inﬂuencing the
expression of genes important for mesodermal differenti-
ation. In laminin c1 knockout mice, BM deposition did not
occur, resulting in the failure of ectoderm formation [131].
Furthermore, the destabilization of collagen IV induced
EMT in renal cell cultures [136].
For proper EMT, the cytoskeleton has to become reor-
ganized to allow the cell to migrate. Therefore, cell-to-cell
contacts have to be reduced, while cell-to-ECM interac-
tions have to be increased. [137]. In the presence of a BM,
the actin cytoskeleton accumulated at the apicolateral
region of the polarized cells, whereas in its absence, actin
was distributed evenly throughout the unpolarized cells.
Therefore, BMs prevent EMT initiation by inﬂuencing the
dynamics of the actin cytoskeleton and the assembly and
disassembly of junctional complexes [131]. During EMT,
laminin-332 gets downregulated, indicating a mechanism
that is important for proper cell invasion. Furthermore, it
has been shown that proteolytic fragments of the laminin
c2 chain liberated by MT1-MMP or MMP2 can trigger cell
migration, therefore one could speculate that these frag-
ments are generated during EMT, thus promoting cell
migration [138].
BMs and EMT: a link to metastasis
Finding candidate marker genes for EMT would also have
implications in cancer diagnosis, prognosis, treatment
[138], and metastasis [139, 140]. EMT-genes such as
Snail2 and Twist2 are also upregulated during cancer
progression [131, 141, 142]. Changes in protein expression
that are indicative of EMT include the upregulation of
vimentin and a reduction in the expression of E-cadherin
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include Wnt, TGFb, Hedgehog, Notch, and NFkB. Nota-
bly, some external stimuli that affect EMT induction
include collagen, ﬁbronectin, EGF, and HGF [138]. Cells
undergoing EMT show a reduced expression of BM com-
ponents such as laminin-332, nidogens and collagen IV a1
and a2 chains in addition to increased expression of pro-
teases, such as MMPs. In addition, these cells demonstrate
elevated secretion of ECM molecules important for the
proliferation and migration of compounds such as collagen
I and ﬁbronectin [138, 143, 144]. Metastatic cells indeed
showed signiﬁcantly decreased to no expression of diverse
laminin subunits, collagen IV and a-dystroglycan com-
pared to their non-metastatic counterparts [145–147]. In
addition, during EMT, the downregulation of laminin a5
and the upregulation of laminin a4 have been observed,
suggesting that tumor cells utilize laminin-411 due to their
invasive behavior [148]. Furthermore, laminins and colla-
gen IV are localized throughout the ECM of some cancer
tissues [149, 150], indicating fragments of these proteins
that are not able to self-assemble into BM structures.
Laminin-332 fragments can improve cancer cell migration
and, for this reason, it has been discussed as a potential
target for cancer therapy [151, 152].
Depending on the stimulus, different MMPs are acti-
vated, such as cells activated by Ras that can upregulate
MMP1. On the other hand, the activation of cells via HGF
or Snail has been shown to activate MAPK signals,
increasing the expression of MMP9 and MMP13 [138].
Furthermore, cell motility can be inﬂuenced by different
integrin dependent pathways, including the Ras-Raf and
MAPKinase or Rho- and Rac-controlled pathways [153,
154].
Adult stem cell niches: in vivo and in vitro
There is evidence that in different sites of the limbal
compartment of the eye, various forms of typical BM
components were localized, indicating that a different
composition of ECM can regulate the phenotypic changes
of the limbal cells and thereby regulate cell differentiation
and migration via diverse cell-ECM-interactions [9]. The
limbal stem cell compartment contains mostly collagen
type IV a1 and a2, whereas collagen IV a5 and a6 chains
were localized throughout the limbal and corneal BMs.
Laminin-211 and -213 were most prominent and were
shown to be speciﬁc for limbal BMs. While both nidogens
and perlecan did not show any regional differences, lami-
nin c3 showed a speciﬁc immunoreactivity in the limbal
stem cell compartment.
The stem cell niche in skin has been recently reviewed
[61]. The BM itself provides proliferative stimuli through
the use of laminin-332 that stimulates anchorage, signaling
and migration via a6b1 integrins at hemidesmosomes and
a3b1 at focal adhesions [155, 156]. Laminin-332 supports
cell adhesion and migration more efﬁciently than other
laminins, which is mainly mediated by integrins a3b1,
a6b1 and a6b4[ 157]. It is important in skin and other
epithelial tissues and it plays important roles in the sta-
bilization of the epidermal-dermal-junction and in wound
healing [157]. More speciﬁcally, it has been shown that the
proliferation potential of such cells can be enhanced via
exposure to b1-integrins [156], which induces focal adhe-
sion tyrosine kinase and Src tyrosine kinase, thereby
stimulating the Ras-MAPK pathway and inducing epider-
mal migration. Balancing these pathways is known to be
important for homeostasis and cancer development [158].
Notch signaling is one of the key mediators for the dif-
ferentiation or the repression of basal cells via the
regulation of integrin levels [61]. Mufﬂer et al. [117]
demonstrated that an increase in MMPs (MMP1 by basal
keratinocytes, MMP2 by dermal ﬁbroblasts) led to the
degradation of collagen IV, laminin-332 and -511, nidogen
and integrins a6 and b1, thereby altering the long-term
differentiation potential of the epidermis, which is thought
to be due to stem cell niche destruction. It has been further
proposed that integrin-nidogen-laminin-332 complexes
could be promising components for the regulation of the
stem cell niche and epidermal maintenance [117]. In vitro,
collagen IV can be used to enrich proliferative human skin
keratinocytes, with high levels of integrin a6 and b1 sub-
units [159]. The a6 integrin subunit has been used for the
isolation of human epidermal stem cells [160].
In the muscle stem cell niche [62, 161], it is suggested
that the BM components regulate satellite cell behavior, as
these cells lose their proliferative capacity in vitro, prob-
ably due to the loss of the BM components of its niche
[162–164]. Several ECM molecules, including BM com-
ponents, affect myoblast differentiation and proliferation
[165, 166]. The inﬂuence of BMs on satellite cells has been
previously reviewed in detail [62]. Laminins in skeletal
muscle interact with cell surface receptors to initiate BM
formation [167]. Furthermore, a muscle-speciﬁc isoform of
laminin-211 [6] has been characterized in the stem cell
compartment that connects cells via integrin a7b1 and
dystroglycan. Integrin a7b1 is also upregulated during the
regeneration of muscle tissue. Integrin a3 plays a role in
satellite cell migration and differentiation. Furthermore, the
integrin b1 in muscle tissue is important in myoblast
attachment in vitro [161, 168]. Laminins have been shown
to give rise to additional yet smaller myotubes, whereas
collagen type IV or Matrigel
 resulted in thicker yet fewer
myotubes. In addition, the stiffness of the surrounding
ECM inﬂuences the proliferation rate of myoblasts,
resulting in higher stiffness associated with increased
proliferation [169]. Yao et al. [170] have described a
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a7b1 integrins.
The stem cell niche of cardiac tissue in vivo has not
yet been described in detail; however, it is known that
fetal heart tissue and adult cardiomyocytes secrete colla-
gen IV and ﬁbronectin [171]. It has been hypothesized
that cardiac stem cells are quiescent cells, surrounded by
a BM, and if activated give rise to cells of the transient
amplifying pool that are responsible for tissue repair
[172]. Laminins in particular are known to play an
essential role in cardiac tissue development, as elucidated
by laminin a2 and a4 mutations [173]. Furthermore,
laminin a4 mutations were shown to also result in
endothelial and cardiac cell alterations [58]. Interestingly,
in heart tissue, BMs are primarily important for the
control of ECM assembly and deposition, thereby indi-
rectly inﬂuencing cell behavior. Malan et al. [174] have
recently shown that a lack of laminin c1 and a corre-
sponding lack of BMs are not essential for the
development and differentiation of hESC into cardio-
myocytes. However, they detected a clearly stronger
deposition of several ECM proteins, e.g., collagen I, VI
and ﬁbronectin, which resulted in an altered spacing
between the cells and indirectly caused a defective
intercellular coupling via gap junctions resulting in
altered propagation of electrical signals. Furthermore,
increased amounts of the pacemaker-like cells were
found, suggesting a compensatory mechanism to over-
come the increased ECM depositions and the alterations
in the propagations of electrical signals. These results
could explain the pathophysiological development of
cardiomyopathies where the deposition of ECM is one of
the main causes for life-threatening arrhythmias [174,
175]. Moreover, collagen IV plays an important role in
cardiac tissue and shows an increased deposition in the
ECM after myocardial infarction (for review, see [176]).
It has been proposed that ECM deposition in heart tissue
could be repressed, either by changing the integrin pattern
to a more laminin-binding pattern and less ﬁbronectin-
binding integrins (a5b1, avb3), which could accelerate
maturation and reduce ECM secretion, or by co-injections
of hESCs with extracellular matrix molecules [125].
A special kind of niche is the vascular niche, which is
important for cellular and developmental processes, for
differentiation and proliferation of the stem and progenitor
cells, as well as for the development of cancer metastasis.
The inﬂuence of the vascular niche in diverse diseases has
been reviewed previously [60, 177]. Despite exhibiting
highly variable features in different tissues, Nikolova et al.
[60] suggested that a common feature of all the vascular
niches is to provide a BM to cells that are unable to form
their own. Furthermore, these cells are dependent on their
vascular niche to retain a high degree of plasticity [60].
Cells that are included in this niche are the endothelial cells
and the smooth muscle cells in the macrovasculature or the
pericytes of the microvasculature. In vitro, endothelial cells
have been shown to be supportive in the differentiation of
pancreatic cells [178], in the stimulation of the neurogen-
esis of neural stem cells [179], and in supporting the
proliferation of myoblasts [180]. Co-transplantations of
hESC-cardiomyocytes with hESC-endothelial cells could
improve the formation of functional capillaries and the
secondarily blood supply [125]. Moreover, recent data
present in vitro and in vivo evidence for the important role
of pericytes–endothelial interactions to stimulate BM for-
mation and thereby stabilize vascular tube formation [181].
Collagen IV promotes the differentiation potential of ESCs
to endothelial cells [182]. Due to their stem cell charac-
teristics and their ability to produce BM components,
pericytes are thought to be important for the function of the
blood–brain barrier [183, 184]. Furthermore, pericytes
enhance the low-tissue regeneration and proliferation
capacity of epithelial cells by inﬂuencing the ECM
microenvironment. Pericytes are a source of laminin a3 and
a5, collagen IV a1 and a2 chains, integrin a7, and integrin
a1 in human skin [184]. In organotypic cocultures, it has
been found that they enhanced the deposition of laminin-
511/521 in the dermal-epidermal junction. These observa-
tions could be used for the ex vivo expansion of epidermal
progenitors to treat skin defects [184]. In muscle tissue, a
loss of capillaries leads to a loss of satellite cells, which is
thought to result from an interaction of endothelial cells
with satellite cells [180]. Furthermore, pericytes are able to
differentiate into mesenchymal lineage cells [185]. There-
fore, pericytes could also be a possible stem cell source in
muscle tissue that would be able to differentiate into
myoblasts. Changes in the BM composition and/or its
destruction in vascular tissues could be important in dif-
ferent diseases, including multiple sclerosis or for diseases
of the pancreas in the context of islet cell transplantation or
autoimmune insulitis [123].
Improvement of culture conditions for adult stem cells
It has been proposed that stem cells require an authentic
equivalent of their in vivo environment, rather than an
artiﬁcial surrogate, such as collagen type I [117]. Mufﬂer
et al. [117] demonstrated a high regenerative capacity of
human epidermal stem cells in scaffold organotypic cul-
tures (OTCs) rather than in OTCs made up of collagen type
I. The imitation of different tissue-speciﬁc ECMs can
promote cell differentiation and proliferation in vitro [186],
as has been shown, for example, by de-cellularized matri-
ces of tissues, which were sufﬁcient for the differentiation
of stem cells into the cells and structures indicative of the
respective tissue [187].
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Mesenchymal stem cells (MSCs) could be a good starting
point for tissue engineering approaches, as they have been
shown to be multipotent cells with self-renewal abilities
and a potential to differentiate into a variety of cell types
[188, 189]. MSCs are proposed to be directed to the sites of
injury [190], suggesting them as a starting point to initiate
regeneration [191, 192]. The observation that systemically
delivered MSCs can integrate into a perivascular/intramu-
ral location has been shown by Toma et al. [192],
indicating that perivascular tissues could function as a
reservoir of tissue-speciﬁc regenerative cells [192]. It has
been proposed that pericytes are a type of MSC and vice
versa, due to their similarities [184, 186]. Potapova et al.
[193] found that endothelial cell migration, invasion
through BMs, proliferation and survival can be supported
by MSCs. Furthermore, MSCs can be differentiated into
vascular cell types [186], whereas pericytes are able to be
differentiated into mesenchymal lineages such as chon-
drocytes, adipocytes and osteocytes [184].
Effect of BM components on adult MSCs
The imitation of bone marrow cell-derived ECM (including
laminin, perlecan, ﬁbronectin, collagen I) in vitro has
resulted in a complete bone-like structure in vivo that
contained hematopoietic marrow with adipocytes and
stromal cells that supported hematopoiesis and osteo-
clastogenesis [194], suggesting that marrow-derived ECM
provides important micro-environmental cues in vivo and
preserves the stem cell properties of MSCs [194]. ESCs
could be differentiated into smooth muscle cells (SMCs)
via collagen IV [195], whereas bone marrow-derived
MSCs signiﬁcantly increased their proliferation rate [188,
196]. Collagen IV positively inﬂuenced the proliferation of
human bone marrow-derived MSCs, whereas laminin-111-
coating enhanced the smooth muscle cell differentiation
marker expression [188].
It has been indicated that laminin-332 plays a sup-
pressive role in chondrogenic differentiation of mouse
embryonal carcinoma-derived chondroprogenitor cell
lines [157]. Additionally rat periosteum, as well as
human MSCs, express laminin-332, which induces oste-
ogenic differentiation via an ERK signaling pathway
[157, 197] suggesting a possible role for laminin-332
during bone development [157]. Laminin-332 has
growth-stimulating activity depending on the type of
target cell [49]. The soluble form of laminin-332 stimu-
lated growth of MSCs via a6b1 integrin, thereby
inhibiting chondrogenic differentiation. Moreover, lami-
nin-332 promoted attachment and spreading of MSCs in
vitro [157]. The suppression to one cell lineage by
laminin-332 may favor the commitment of MSCs to
other cell lineages (adipocytes or myoblasts) as proposed
by Hashimoto et al. [157].
Perlecan might improve the bioavailability of diverse
growth factors in vitro to increase the proliferation and
differentiation potential of MSCs. BMPs and TGFbs are
widely used in vitro to improve chondrogenesis [198] and
for mesenchymal stem cell-like cells from human osteo-
arthritis (Fig. 6) as described recently [199].
Fig. 6 Tissue from late stages
of osteoarthritis exhibits brakes
in the tidemark (a) through
these mesenchymal cells and
blood vessels enter the cartilage
tissue (b), perhaps bring in stem
cells from the mesenchyme
underneath (c). The progenitor
cells are positive for STRO-1
(d) and CD29 (e), two so-called
stem cell marker. (Taken from
[199], with permission from the
publisher)
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Understanding of the structure and components of the
human BMs in different tissues would have important
implications for the development of more physiologically
relevant conditions for the optimized cell growth and dif-
ferentiation of cell lines in vitro, due to the importance of
environment in maintaining speciﬁc cell properties in vitro.
Mimicking a tissue-speciﬁc stem cell niche will help
facilitate stem cell self-renewal and create a controlled
differentiation ex vivo environment. The identiﬁcation of
speciﬁc niche parameters of diverse tissue types in vivo
will not only help to understand stem and progenitor cell
regulation but will also further improve their enrichment
and in vitro expansion for cell biologically relevant ther-
apeutic strategies. It has been shown that BM components
could be used to create an in vivo-situation for maintaining
stem cell properties and that they are a useful tool in tissue
engineering techniques. The receptor expression pattern of
integrins, for example, and their signaling pathways in
hESC and adult stem cells requires further investigation to
produce a better understanding of how stem cells modulate
their speciﬁc environment to create optimal niche condi-
tions. Further work is needed to understand the complex
microenvironments created mainly by BM components of
different tissues, their stem cells and progenitors during
homeostasis, diseases and repair.
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